相关实验视频

Updated: Jun 4, 2025

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.3K

血细胞淋巴细胞细胞细胞结合后的奇默性抗原受体T细胞疗法

Jing-Ming Wang1,2, Hui-Wen Jiang1,2, Yin-Qiang Zhang1,2

  • 1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Expert review of clinical immunology
|December 27, 2024
PubMed
概括

免疫效应细胞相关的HLH类综合征 (IEC-HS) 是CAR-T治疗中的一个严重疾病. 早期诊断和综合管理对于改善这种致命综合征患者的治疗结果至关重要.

关键词:
化学抗原受体T细胞治疗细胞因子释放综合征 细胞因子释放综合征血细胞性淋巴细胞化.免疫效应细胞相关的HLH类综合征免疫效应细胞相关的神经毒性综合征

更多相关视频

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

14.9K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

458

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475